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The intracardiac electronic device implantation rate has
been constantly increasing for the last 20 years and is
accompanied by an increasing lead extraction rate. Percuta-
neous extraction of transvenous leads of cardiovascular
implantable electronic devices is mandatory in the case of
pocket infection and/or system infection, resulting in valv-
ular or lead endocarditis.1 Lead extraction is also performed
in the case of venous thrombosis or stenosis and non-
functioning leads. When leads have been implanted for more
than 1 year, device-assisted extraction may be necessary.
Locking stylets and dissection sheaths are common extrac-
tion tools.Case report
To the best of our knowledge, we report the ﬁrst in vivo
visualization of a partial extravascular course of 2 pacemaker
leads (Figure 1).
The incidental ﬁnding of a partial extravascular course of
these 2 leads was observed in a 43-year-old man with
trisomy 21 who had been operated for atrioventricular septal
defect at the age of 6 years. An epicardial pacemaker was
implanted at that time owing to postoperative complete
atrioventricular block. At the age of 18, he received his ﬁrst
endocardial DDD pacemaker and a fourth pacemaker
replacement was performed at the age of 42. Pocket infection
was observed 6 months later. Transvenous extraction was
attempted for the 2 leads that had been inserted for 24 years
with surgical backup. The ventricular lead (Celsa 1823M)
and the atrial lead (Medtronic 6957J) were reinforced by 2
locking stylets. A 16F laser sheath (Spectranetics, Colorado
Springs, CO) was introduced around the 2 leads, but was
blocked in the innominate vein by what was thought to be
very dense ﬁbrosis or massive calciﬁcation. We did not useKEYWORDS Endovascular lead; Device-assisted extraction; Pacemaker
infection
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phageal echocardiography did not show any pericardial
effusion. Transvenous device-assisted lead extraction was
abandoned and sternotomy was performed in order to
remove the leads. After opening the pericardium, the surgeon
observed that the 2 leads were partially located outside of the
left innominate vein (Figure 1). Left innominate vein
laceration would have occurred if the laser sheath had been
advanced further along the extravascular course of the leads.
Lead extraction was then performed under cardiopulmonary
bypass (Figure 2) and a new pacemaker was inserted
epicardially.Discussion
Mechanical or powered (electrical or laser) dissection
sheaths allow release of pacemaker leads from the ﬁbrotic
process. Strict intravascular sheath progression is guided by
the course of the lead during sheath progression. Extraction
sheaths also allow countertraction to limit the risk of
myocardial tears. Nevertheless, with time, the ﬁbrotic
process worsens and may result in an “encapsulation”
phenomenon.2 After a number of years, leads may be
included in the wall of the vein or the myocardium. Trans-
venous extraction of leads may be hazardous despite the use
of speciﬁc tools. The mortality rate reported in the most
recent series ranges between 0.3% and 1.86%.3,4 Causes of
deaths were reviewed in the study by Hauser et al.5 Deaths
were due to myocardial perforation and venous laceration
(left innominate vein and superior vena cava) in 59% of
cases. Surgical repair is associated with a mortality rate of
56%.5 Cardiac perforation or vascular lacerations may be
related to false passage of the sheath or wall dissection in the
case of an encapsulated lead, justifying systematic surgical
backup. In this case, sheath progression was blocked at the
site of the extravenous course of the lead subsequently
observed by the surgeon. Continuation of transvenous lead
extraction without conversion to cardiac surgery could have
been disastrous in the present case, although we cannot
exclude the possibility of an uneventful outcome in case of
local bleeding in a closed space. Forcible lead extraction
using a powered dissection sheath should be avoided,pen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.04.005
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Figure 2 The right atrium was opened under cardiopulmonary bypass to
remove the 2 leads.
KEY TEACHING POINTS
 A partial extravenous course of device leads may be
present in the case of longstanding
pacemaker leads.
 Partial extravenous lead may represent a major risk
of vascular perforation during transvenous device-
assisted lead extraction.
 Methods for the detection of extravenous or
extracardiac pacemaker lead before extraction are
lacking.
 Forcible lead extraction using a powered dissection
sheath should be avoided, especially in the case of
a longstanding pacemaker lead. Conversion to
cardiac surgery is preferable in such cases.
 Referral to highly experienced surgeons that
perform a high volume of procedures is mandatory
for all cases of lead extraction, together with
systematic surgical backup.
507Hermida et al Partial Extravenous Course of Cardiac Pacemaker Leadsespecially in the case of a longstanding pacemaker lead.
Conversion to cardiac surgery is preferable in such cases.
The extravenous course of the pacemaker leads was not
visible on radiographs. Preoperative computed tomography
(CT) scan was not performed in this patient. We do not knowP
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Figure 1 A and B indicate the 2 cardiac pacemaker leads. Their courses are lo
Ao ¼ aorta; P ¼ pericardium; RAA ¼ right atrial appendage; RV ¼ right ventricwhether CT scan would have been useful. It is likely that the
extravenous course of the 2 leads would not have been
detected owing to metal-induced artefacts. Nevertheless, we
intend to systematically perform cardiac CT scan in all future
cases of longstanding lead extraction.
Conclusion
A partial extravenous course of device leads may occur in
the case of longstanding leads, which can explain cases of
cardiac or vein perforation observed during transvenous lead
extraction.LIV
B
A
cated outside of the superior part of the left innominate vein (LIV) lumen.
le.
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